Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04225299
What this trial is testing

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Who this might be right for
Localized Prostate Cancer
Steba Biotech S.A.
Not applicableEnded earlyNCT02478112
What this trial is testing

Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)

Who this might be right for
Prostate Cancer
Centre Oscar Lambret 24
Not applicableLooking for participantsNCT05438563
What this trial is testing

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Who this might be right for
Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT00888654
What this trial is testing

Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 41
Not applicableStudy completedNCT01542021
What this trial is testing

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate CancerProstatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00003104
What this trial is testing

Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT04984343
What this trial is testing

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 33
Large-scale testing (Phase 3)Study completedNCT00067015
What this trial is testing

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 3
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07393867
What this trial is testing

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Who this might be right for
Intermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer
Martin T. King, MD, PhD 23
Not applicableStudy completedNCT01379872
What this trial is testing

Assessment of New Radiation Oncology Technologies and Treatments

Who this might be right for
Prostate Cancer (Post Prostatectomy)Anal CancerNasopharyngeal Cancer+1 more
Trans Tasman Radiation Oncology Group 138
Early research (Phase 1)Looking for participantsNCT05864196
What this trial is testing

Two Fraction Prostate SBRT With DIL SIB

Who this might be right for
Prostate Cancer
NYU Langone Health 80
Not applicableUnknownNCT02895854
What this trial is testing

LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Kuopio University Hospital 44
Not applicableEnded earlyNCT01737151
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer
Virginia Commonwealth University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04465500
What this trial is testing

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Virginia 60
Not applicableLooking for participantsNCT02865330
What this trial is testing

Spanish Urological Association Registry of Patients on Active Surveillance

Who this might be right for
Prostate Cancer
Fundación Instituto Valenciano de Oncología 946
Testing effectiveness (Phase 2)Study completedNCT00006365
What this trial is testing

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 138
Large-scale testing (Phase 3)Active Not RecruitingNCT01584258
What this trial is testing

Prostate Advances in Comparative Evidence

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 2,205
Testing effectiveness (Phase 2)Study completedNCT02770391
What this trial is testing

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 54
Not applicableUnknownNCT04100811
What this trial is testing

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Who this might be right for
Prostate Cancer
miR Scientific LLC 2,019
Next Page